The transaction includes Roche's acquisition of Alnylam's European research site in Kulmbach, Germany (Bavaria), with about 40 employees. The team in Kulmbach will remain dedicated to RNAi ...

Post-pandemic travel trends in Germany As pent-up demand to see Europe seems to be cooling, it's interesting to see some of the numbers and take a stab at predicting ...

KULMBACH, Germany and ALPHARETTA, Ga., May 28, 2025 (GLOBE NEWSWIRE) -- Aptean Inc., a global front-runner of AI-driven ERP solutions, is pleased to announce the acquisition of Vlexgroup AG ...

As FierceBiotech reported yesterday, Roche singled out its work in RNAi when choosing its R&D targets for the budget axe, announcing plans to shutter the work underway in Kulmbach, Germany, ...